KR20130114210A - 스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물 - Google Patents

스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물 Download PDF

Info

Publication number
KR20130114210A
KR20130114210A KR1020137018851A KR20137018851A KR20130114210A KR 20130114210 A KR20130114210 A KR 20130114210A KR 1020137018851 A KR1020137018851 A KR 1020137018851A KR 20137018851 A KR20137018851 A KR 20137018851A KR 20130114210 A KR20130114210 A KR 20130114210A
Authority
KR
South Korea
Prior art keywords
clfa
immunogenic composition
protein
lyophilized
staphylococcus aureus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137018851A
Other languages
English (en)
Korean (ko)
Inventor
라크쉬미 칸드케
아키히사 노노야마
타마라 샤퍼 핫쥐
샌딥 니마
Original Assignee
와이어쓰 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 와이어쓰 엘엘씨 filed Critical 와이어쓰 엘엘씨
Publication of KR20130114210A publication Critical patent/KR20130114210A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
KR1020137018851A 2010-12-22 2011-12-21 스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물 Ceased KR20130114210A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061426476P 2010-12-22 2010-12-22
US61/426,476 2010-12-22
PCT/IB2011/055883 WO2012085872A2 (en) 2010-12-22 2011-12-21 Stable immunogenic compositions of staphylococcus aureus antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020157031951A Division KR101808398B1 (ko) 2010-12-22 2011-12-21 스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물

Publications (1)

Publication Number Publication Date
KR20130114210A true KR20130114210A (ko) 2013-10-16

Family

ID=45444677

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137018851A Ceased KR20130114210A (ko) 2010-12-22 2011-12-21 스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물
KR1020157031951A Expired - Fee Related KR101808398B1 (ko) 2010-12-22 2011-12-21 스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020157031951A Expired - Fee Related KR101808398B1 (ko) 2010-12-22 2011-12-21 스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물

Country Status (18)

Country Link
US (1) US20130259896A1 (enExample)
EP (2) EP2654784B1 (enExample)
JP (1) JP6097478B2 (enExample)
KR (2) KR20130114210A (enExample)
CN (1) CN103826656B (enExample)
AU (1) AU2011346535B2 (enExample)
BR (1) BR112013016153A2 (enExample)
CA (1) CA2819120C (enExample)
DK (2) DK2654784T3 (enExample)
ES (2) ES2614815T3 (enExample)
HU (2) HUE047263T2 (enExample)
IL (1) IL226793B (enExample)
MX (1) MX350170B (enExample)
PL (2) PL2654784T3 (enExample)
PT (2) PT3150222T (enExample)
RU (1) RU2570730C2 (enExample)
SI (2) SI3150222T1 (enExample)
WO (1) WO2012085872A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540770T3 (es) 2004-09-22 2015-07-13 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
SG10201406432RA (en) 2009-06-22 2014-11-27 Wyeth Llc Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
HUE036372T2 (hu) 2009-06-22 2018-07-30 Wyeth Llc Staphylococcus aureus antigének immunogén készítményei
US9095567B2 (en) * 2010-06-04 2015-08-04 Wyeth Llc Vaccine formulations
EP2686010A2 (en) * 2011-03-16 2014-01-22 Regents of the University of Minnesota Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
GB201310008D0 (en) * 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
MX370488B (es) * 2013-12-04 2019-12-16 Glaxosmithkline Biologicals Sa Prevencion de infecciones por staphylococcus aureus mediante vacunas de glucoproteina sintetizadas en escherichia coli.
IL310015B1 (en) * 2013-12-31 2025-10-01 Access To Advanced Health Inst Single vial formulation
EP3129001B1 (en) * 2014-04-10 2019-10-02 ASIT BioTech s.a. Hsp-free allergen preparation
KR20200040812A (ko) * 2017-08-16 2020-04-20 머크 샤프 앤드 돔 코포레이션 폐렴구균 접합체 백신 제제
GB201802339D0 (en) 2018-02-13 2018-03-28 Glaxosmithkline Biologicals Sa Immunogenic composition
KR102649069B1 (ko) 2018-05-31 2024-03-19 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
KR102058961B1 (ko) * 2018-07-28 2019-12-24 주식회사 엑소코바이오 엑소좀의 동결건조 방법
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
IL294461A (en) * 2020-01-13 2022-09-01 Aptevo Res & Development Llc Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6008341A (en) 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5700928A (en) 1995-10-16 1997-12-23 Smithkline Beecham, P.L.C. Polynucleotide encoding saliva binding protein
GB9622159D0 (en) 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
GB9622660D0 (en) 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
EP1034277B1 (en) 1997-11-26 2012-06-27 Inhibitex, Inc. Extracellular matrix-binding proteins from Staphylococcus aureus
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
CN1314450C (zh) * 1998-08-31 2007-05-09 英希比泰克斯公司 多组分疫苗
US6936258B1 (en) 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7115730B1 (en) 1999-04-27 2006-10-03 Chiron Srl Immunogenic detoxified mutant E. coli LT-A-toxin
US7384640B1 (en) 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
CZ304195B6 (cs) 2000-06-08 2013-12-27 Intercell Ag Imunostimulační farmaceutický přípravek
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
WO2002098368A2 (en) 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
AU2002322380B2 (en) 2001-06-07 2006-11-02 Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences Mutant forms of cholera holotoxin as an adjuvant
EP1423701B1 (en) 2001-06-15 2012-07-25 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
JP5102487B2 (ja) 2003-03-07 2012-12-19 ワイス・ホールディングズ・コーポレイション 院内感染に対する免疫化のための多糖ブドウ球菌表面付着因子キャリアタンパク質接合体
EP1603950A2 (en) 2003-03-17 2005-12-14 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
ES2540770T3 (es) * 2004-09-22 2015-07-13 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
AR060187A1 (es) * 2006-03-30 2008-05-28 Glaxosmithkline Biolog Sa Composicion inmunogenica
EA020459B1 (ru) * 2006-03-30 2014-11-28 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция
GB0606416D0 (en) * 2006-03-30 2006-05-10 Glaxosmithkline Biolog Sa Immunogenic composition
US20070253985A1 (en) 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
MX2009004862A (es) * 2006-11-07 2009-07-17 Sanofi Pasteur Biologics Co Estabilizacion de vacunas por liofilizacion.
AU2009221180B2 (en) 2008-03-05 2014-02-13 Sanofi Pasteur Process for stabilizing an adjuvant containing vaccine composition
HUE036372T2 (hu) * 2009-06-22 2018-07-30 Wyeth Llc Staphylococcus aureus antigének immunogén készítményei

Also Published As

Publication number Publication date
SI2654784T1 (sl) 2017-01-31
HUE033072T2 (hu) 2017-11-28
AU2011346535B2 (en) 2015-09-24
KR20150129071A (ko) 2015-11-18
JP2012136518A (ja) 2012-07-19
RU2013128277A (ru) 2015-01-27
MX350170B (es) 2017-08-28
CA2819120C (en) 2016-07-05
ES2614815T3 (es) 2017-06-02
SI3150222T1 (sl) 2020-02-28
PL2654784T3 (pl) 2017-08-31
AU2011346535A1 (en) 2013-06-13
EP3150222A1 (en) 2017-04-05
PT3150222T (pt) 2020-02-03
US20130259896A1 (en) 2013-10-03
CN103826656B (zh) 2015-08-26
HK1197370A1 (en) 2015-01-16
DK2654784T3 (en) 2017-02-13
HUE047263T2 (hu) 2020-04-28
KR101808398B1 (ko) 2017-12-12
PL3150222T3 (pl) 2020-05-18
BR112013016153A2 (pt) 2017-07-11
RU2570730C2 (ru) 2015-12-10
WO2012085872A2 (en) 2012-06-28
EP3150222B1 (en) 2019-11-27
IL226793B (en) 2019-02-28
ES2769425T3 (es) 2020-06-25
DK3150222T3 (da) 2020-01-27
CA2819120A1 (en) 2012-06-28
JP6097478B2 (ja) 2017-03-15
CN103826656A (zh) 2014-05-28
EP2654784B1 (en) 2016-12-07
MX2013006960A (es) 2013-07-15
EP2654784A2 (en) 2013-10-30
WO2012085872A3 (en) 2012-08-30
PT2654784T (pt) 2017-02-13

Similar Documents

Publication Publication Date Title
KR101808398B1 (ko) 스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물
KR101486122B1 (ko) 스타필로코커스 아우레우스 항원의 면역원성 조성물
JP6393804B2 (ja) 組成物および黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）血清型５および８莢膜多糖コンジュゲート免疫原性組成物を調製するための方法
RU2672053C2 (ru) Способ гликоконъюгации
US8986710B2 (en) Neisseria meningitidis compositions and methods thereof
KR20130079536A (ko) 네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
US10829521B2 (en) Neisseria meningitidis composition and methods thereof
HK1197370B (en) Stable immunogenic compositions of staphylococcus aureus antigens

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20130718

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150114

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150727

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150114

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20150727

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20150316

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20151007

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20150827

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20150727

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20150316

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20150114

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20151106